drugset / Trial / NCT02158585

Study of Lamotrigine to Treat Ménière's Disease

NCT02158585

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.

Timeline

Start
2014-06
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lamotrigine Small molecule 150 mg Oral

Indications